Great Point Partners’s MoonLake Immunotherapeutics MLTX Stock Holding History

Great Point Partners’s Portfolio MLTX Stock Details MLTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.32M	Buy
2023 Q2	–	Sell
2023 Q1	$5.95M	Sell
2022 Q4	$6.75M	Buy
2022 Q3	$3.82M	Buy
2022 Q2	$2.27M	Buy